GeneChem is a manager of focused venture capital funds. Since 1997, we have been involved in the launching of companies and in the management of their growth and liquidity events.

GeneChem has been part of investment syndicates which included a wide breadth of marquee international investors as well as smaller local players. The team has knowledge and expertise in various fields of science including biochemistry, chemistry, immunology, oncology, virology, bacteriology, analgesia, ophthalmology and human genetics.

We have invested at the very early stages of start-ups, where hands-on management is required, and also at the later stages such as mezzanine rounds and private placements in public entities. The team's experience is broad and deep-reaching within the biotech investment sector.

1 Westmount Square, Suite 800
Montreal, Quebec
H3Z 2P9

T 514-849-7696
F 514-849-5191

Maxime Pesant, CPA, CMA, CFA Vice-President, Finance

M. Pesant joined the team subsequently to the closing of AgeChem. Previously, he worked for GeneChem as a consultant and spent two years at CDP Capital Technologies – Biotechnologies as a Junior Analyst. He also held positions of Financial Analyst for various small businesses. M. Pesant received a Bachelor in Business Administration from HEC Montreal in 2004 and is a member of the Ordre des CPA du Québec. He is also a CFA charterholder.

T 514-849-4692
F 514-849-5191



HomeAbout UsGeneChem TechGeneChem TheraAgeChemAmorChemNuChemOur TeamContact UsFrançais

© 2024 GeneChem. All rights reserved. Developed by Grafika Designs a Montreal Web Design company.